Riociguat is a novel medication for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Pulmonary hypertension (PH) is a progressive and potentially dangerous, life-threatening disease. A variety of different diseases can be associated with a pathological increase in the average pulmonary artery pressure, hence PH is a very diverse entity. The pathophysiology of PH is extremely variabl...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2016-12-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/72 |